THE MEN BEHIND WELLBEING — Chapter Three
Following Andrew Chancellor’s Corporate Trail
Before regenerative medicine came banking and recruitment. What does the documentary record tell us about the businessman who became Wellbeing’s CEO?
The previous two chapters raised an important question.
How did Andrew Chancellor move from banking and international recruitment to becoming Chief Executive Officer of an organisation delivering regenerative biologics?
Wellbeing International Foundation’s own biography describes a career spanning more than thirty years: international banking in South Africa and Britain, followed by recruitment businesses operating across London, Paris, Hong Kong, Singapore and Sydney, and eventually approximately fifteen years working in healthcare and bioscience.
That history is important.
But corporate biographies are written to introduce people.
They are not due-diligence reports.
So I started looking backwards.
Before Wellbeing
One useful discovery takes us back almost twenty years.
In February 2007, recruitment-industry publication Onrec identified an Andrew Chancellor as the London-based head of the banking and finance team at Robert Walters.
He was quoted discussing the shortage of corporate-finance professionals in London and the increasing recruitment of talent from Hong Kong and Singapore.
That is significant because it independently corroborates an important part of Chancellor’s stated career history.
Long before regenerative medicine, he was publicly speaking as a specialist within financial recruitment.
There is nothing problematic about that.
Quite the opposite.
It helps establish the timeline.
Banking → Recruitment → Bioscience
Wellbeing describes Chancellor’s career as beginning in international banking before moving into executive recruitment.
Chancellor’s more recent public interviews tell essentially the same story.
Eventually he met Stephen Ray, the scientist associated with the research underpinning Wellbeing.
Chancellor describes what happened next in distinctly commercial terms.
Their conversations developed into discussions about how to commercialise the research and construct an organisation capable of bringing it into clinical use.
That appears to be the bridge.
Chancellor did not arrive in regenerative medicine through medical school.
Nor does Wellbeing describe him as having spent his early career conducting biomedical research.
He appears to have arrived through business.
And there is nothing inherently wrong with that.
The question is what happened afterwards.
The Businessman Becomes a Biotechnology Executive
This distinction matters because Chancellor’s current public profile is increasingly associated with medicine and bioscience.
Recent business publications describe him as CEO of a regenerative-medicine organisation and discuss his experience in bioscience leadership.
Wellbeing itself says that during approximately the last fifteen years he has worked in healthcare and bioscience, translating research into clinical practice.
But the documentary trail before Wellbeing remains overwhelmingly commercial.
Banking.
Recruitment.
International executive search.
Management.
Commercialisation.
That makes reconstructing the businesses between recruitment and Wellbeing particularly important.
And one corporate record initially appeared extremely interesting.
Illuminate Technologies
UK Companies House contains records for a company originally called Illuminate Technologies UK Limited, company number 11201475.
The company was subsequently renamed ITUKL Realisations Limited.
Companies House records show an Andrew Chancellor associated with the company as a director.
A filing dated February 2022 specifically records a change to the director details of a Mr Andrew Chancellor.
Third-party corporate records also identify an Andrew Chancellor among Illuminate’s directors.
Then the company ran into serious trouble.
Administration
Companies House records establish that Illuminate Technologies UK Limited entered administration.
The subsequent filing history contains administrator proposals, a statement of affairs, progress reports, a change of name to ITUKL Realisations Limited and continuing administration documentation.
On the surface, that appears potentially significant.
A company associated with an Andrew Chancellor.
A technology business.
A directorship.
And eventually administration.
It would be tempting to immediately add this to Chancellor’s corporate history.
But that would be bad investigative journalism.
We Have an Identity Problem
There are many people called Andrew Chancellor.
And this investigation has already encountered several of them.
Some are doctors.
Some are scientists.
Some are academics.
Some are businessmen.
Simply finding the same name on Companies House is not sufficient evidence that two records belong to the same person.
That principle matters particularly here.
At present, I have found a Companies House record identifying an Andrew Chancellor as a director of Illuminate Technologies UK Limited.
I have not yet established to the evidential standard required for publication that this individual is the same Andrew Chancellor who now runs Wellbeing International Foundation.
That means this investigation stops at the boundary of what can be proven.
For now.
Why I Am Publishing the Uncertainty
Some readers might wonder why mention Illuminate at all if the identity has not been confirmed.
Because this series is also about showing how investigations actually work.
A search result is not evidence.
A matching name is not identification.
A corporate database is not necessarily proof.
A journalist can easily begin with the conclusion they want and then collect records appearing to support it.
That is exactly what I do not intend to do.
The correct approach is the opposite.
Find the record.
Test it.
Attempt to disprove the connection.
Then publish only what survives.
So the Illuminate file remains marked:
IDENTITY MATCH NOT YET ESTABLISHED.
No allegation should be made against Chancellor on the basis of that company unless the connection is independently confirmed.
And Even If It Is Him…
There is another equally important principle.
Suppose we ultimately establish conclusively that Wellbeing’s Andrew Chancellor was a director of Illuminate.
That still would not mean he caused the company’s failure.
Companies enter administration for countless reasons.
Market conditions.
Funding problems.
Loss of customers.
Debt.
Failed expansion.
Management decisions.
External shocks.
A director’s presence on a company’s records does not establish personal responsibility for its insolvency.
We would then need to establish:
When was Chancellor appointed?
What was his role?
When did he leave?
Was he still a director when financial problems developed?
What do the administrators say caused the company’s difficulties?
What did the statement of affairs show?
Were directors criticised?
Were transactions challenged?
Were any findings made against Chancellor personally?
Only then could responsible conclusions be drawn.
This Is How Lewinsohn Was Investigated
That standard matters because we applied the same approach when examining Max Lewinsohn.
Corporate failure itself is not misconduct.
Litigation itself is not misconduct.
Being named in a court case does not mean someone lost it.
Being a director of a failed company does not mean someone caused the failure.
The documents have to tell us what actually happened.
Andrew Chancellor deserves exactly the same standard.
The Public Biography Is Changing
There is another interesting element to Chancellor’s recent public presence.
He has begun appearing increasingly frequently in business and wellness publications.
Articles discuss leadership, international expansion, health and wellness, regenerative medicine and business culture.
His biographies repeatedly emphasise the same transition:
banking → recruitment → bioscience leadership.
That consistency is useful.
It means the broad career story is not particularly mysterious.
The missing section is more specific.
What companies and commercial ventures occupied the period between international recruitment and today’s Wellbeing organisation?
That is where the investigation now needs to concentrate.
Wellbeing Says Fifteen Years
Wellbeing says Chancellor has spent approximately fifteen years in healthcare and bioscience.
That potentially takes his involvement back to around the beginning of the 2010s.
Wellbeing’s public LinkedIn presence, meanwhile, identifies the organisation as founded in 2015.
That leaves an interesting period to reconstruct.
What was Chancellor doing in bioscience before Wellbeing?
Which companies was he involved with?
What was his relationship with Stephen Ray during those years?
What technology was being developed?
Who financed it?
Who owned it?
And how did those earlier activities eventually become the organisation we see today?
Those are now important questions.
The Stephen Ray Connection
The relationship with Stephen Ray may provide the bridge.
Wellbeing describes Ray as its Senior Scientific Consultant and credits him with decades of research experience in cell therapy.
Chancellor says meeting Ray changed the direction of his professional life.
According to Chancellor, what began as conversations about the underlying biology developed into discussions about commercialisation.
That means the next stage of the corporate investigation cannot examine Chancellor in isolation.
We need to understand the businesses surrounding Chancellor and Ray together.
That is likely where the origins of the present commercial model will become clearer.
What We Can Say Today
After examining the record presently available, several points can be stated confidently.
Andrew Chancellor’s documented background is overwhelmingly commercial.
His career included banking and senior international financial recruitment before regenerative medicine. Historical recruitment-industry reporting independently supports at least part of that account.
Wellbeing says he subsequently spent around fifteen years working in healthcare and bioscience.
Chancellor says his relationship with Stephen Ray eventually developed into discussions about commercialising Ray’s research.
He ultimately became CEO of Wellbeing.
Those facts are established.
What remains incomplete is the corporate bridge connecting them.
Follow the Companies
This investigation therefore moves into a different phase.
Instead of reading biographies, we begin constructing a corporate timeline.
Company by company.
Director by director.
Shareholder by shareholder.
We need to establish:
Which companies Chancellor directed.
Which companies Stephen Ray directed.
Where those directorships overlap.
Who financed those companies.
Which entities owned the technology.
Which companies succeeded.
Which failed.
Which were dissolved.
Which entered insolvency.
And ultimately:
How did the intellectual property and commercial relationships move from those earlier ventures into Wellbeing International Foundation?
That could reveal far more than any biography.
Conclusion
Andrew Chancellor’s career change is not itself suspicious.
People reinvent themselves.
Bankers become entrepreneurs.
Recruiters become chief executives.
Businesspeople enter biotechnology.
Some become exceptionally successful at it.
The interesting question is not why Chancellor changed industries.
It is what happened during the transition.
Because somewhere between international financial recruitment and today’s multimillion-pound possibilities surrounding regenerative medicine lies the origin of the modern Wellbeing business.
And that is the part of the story we have not yet fully reconstructed.
The corporate trail may help us do it.
But this investigation will not attach a failed company to a man simply because the name matches.
We will prove the connection first.
Then—and only then—will we examine what happened.
Comments